Metaxalone
- Product NDC
- 0591-2341
- 11-digit product format
- 005912341
- Labeler code
- 0591
- Product ID
- 0591-2341_ca4c1e06-87e3-4f44-aeac-3da9d4b901d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA203695
- Marketing category
- ANDA
- Marketing start
- 2017-06-19
- Substance
- METAXALONE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Metaxalone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METAXALONE | 800 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1NMA9J598Y |
| Rxcui | 351254 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0591-2341-01 | Metaxalone | 100 in 1 BOTTLE | TABLET | 100 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0591-2341 | METAXALONE TABLET [ACTAVIS PHARMA, INC.] | 8 | Current NDC, Legacy NDC, 1 package rows | 20240801_b3a4f6bc-abd4-4b8e-970f-59b3aa6f17a0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0591-2341-01 | 00591234101 | 100 TABLET in 1 BOTTLE (0591-2341-01) | 100 tablet | 2017-06-19 | 0000-00-00 | No | No | Current |